Annual Report 2024
Mission
The Institute for Advanced Medicine’s mission is to lead the field in providing compassionate, inclusive, integrated, and holistic primary care, prevention, and education to advance the health of individuals and communities.
Vision
The Institute for Advanced Medicine envisions a future where everyone has access to quality health care through culturally affirming services that are guided by data-driven decisions, ensuring equity for all.
About Us
IAM achieves its mission through an extensive network of caring clinicians and supportive programs to meet the unique needs of its patients. We unite the Mount Sinai Health System’s outstanding physicians and staff from multiple disciplines into one integrated program for comprehensive services. Our unique programs, highlighted throughout this report, are designed to benefit and provide compassionate care to the diverse people we serve throughout New York City.
Dear Friends and Colleagues,
The annual report for the Institute for Advanced Medicine (IAM) at the Mount Sinai Health System highlights the developments, transformations, and progress that occurred during 2024.
IAM provided high-quality primary care and supportive services to over 18,000 individuals in 2024. We continue to expand our patient population, reduce no-show rates, and expand the availability of services including endocrinology, geriatrics, gynecology, harm reduction, high-resolution anoscopy, and renal services. We greatly expanded the administration of long-acting injectable medication for HIV prevention and treatment within our program.
IAM received multiple continuation funding awards, as well as new awards for dental services and the expansion of harm-reduction services. We are building on our status as a legacy HIV program to provide primary care services to all.
On behalf of the IAM, we thank our patients, staff, and supporters for taking this journey with us in 2024, and for continuing to be part of the effort to provide compassionate, inclusive, and comprehensive care to our diverse community.
Michael Mullen, MD Executive Director
Matt Baney, MS Senior Director of Business and Strategic Development
Jean DiNapoli, DNP, RN Senior Director of Clinical Services and Administration
2024 Accomplishments
14,250 Patients Received 76,557
Clinical Visits
11,418 Patients Received 31,699
Primary Care Services
2,779 Patients Received 15,226
Mental Health Services
3,979 Patients Received 8,016
Social Work Services
272 Patients Received 924
Point-of Care HIV Rapid Tests
1,058 Patients received Hepatitis C Tests
5,219
Patients served by Samuels
Pharmacy with 41,877 Rx orders (including 1,997 IAM patients with 28,992 Rx orders)
3,369
Patients served by Downtown
Pharmacy with 39,648 Rx orders (including 3,128 IAM patients with 34,976 Rx orders)
4,786 People Received Sexually Transmitted Infection (STI) Screenings
1,223 People Received 235 PrEP Services, and 85 Received 235 PrEP Injections
363 People Received PEP Services
Of the 8,715 People with HIV who were seen by IAM providers:
1,675 Received Oral Health Care Services
691 Received Care Coordination Services
316 Received Food and Nutrition Services
8,066 Received Primary Care Services
Of the 5,161 People Who Identify as Transgender and Gender Diverse who were seen by IAM providers:
554 Received 1,504 Primary Care Services
1,077 Are on a Surgical Path
2,337 Received Hormonal Therapy
994 Received 2,073 Mental Health Services
885 Received 974 Case Management or Psychosocial Services
Patient Demographics
Age
Gender
Race/Ethnicity
Overview of Services
Clinical Services
Primary Care Medical Care
Dental Services
Pre-Exposure Prophylaxis (PrEP)
Post-Exposure Prophylaxis (PEP)
TelePrEP
HIV Prevention, Testing, Care, and Treatment
Mental Health Services
Hepatitis C Screening and Treatment
Integrative Medicine
Pain Management
LGBTQIA Health Services
Center for Transgender Medicine and Surgery (CTMS)
Sexually Transmitted Infection (STI)
Screening and Treatment
Long-Acting Injectables (LAI)
Specialty Services
Cardiology
Dermatology
Endocrinology
Gastroenterology
Geriatric Medicine
Gynecology
High Resolution Anoscopy
Neurology
Pharmacy Services
Support Services
Social Work/Case Management
Care Coordination
Adherence Support
Substance Use and Harm-Reduction Services
Nutrition Services
Health Education and Risk Reduction
Re-Entry Services
Crime Victims Treatment Center
Community-Based Services
IAM Services
HIV, HCV, STI Testing
Street Outreach
24-Hour PEP Hotline
Risk Reduction
Health Education
Workshops
Supplemental Services via Community Partnerships
Housing
Legal Services
Food Pantries, Meals, and Vouchers
Vocational Training
Support Groups
Substance Use Treatment
Mental Health Services
Additional Health Services
Long-Acting Injectable HIV Medications
Long-acting injectable (LAI) HIV medications are playing a significant role in HIV prevention and treatment. If a patient experiences barriers to taking daily pills, LAI medications are a highly effective alternative. This breakthrough approach means that patients can get the prevention or treatment they need through monthly, bimonthly, or biannual injections. The Institute for Advanced Medicine pioneered the use of LAI in 2022.
LAI Antiretroviral Therapy (ART) for HIV Prevention
LAI medications are playing a significant role in HIV prevention through the use of LAI-PrEP (Pre-Exposure Prophylaxis) and LAI-ART (antiretroviral therapy). LAIPrEP, specifically cabotegravir, is an injectable form of PrEP that can be given every eight weeks, offering a less frequent and more convenient alternative to daily oral PrEP. LAI-ART, like cabotegravir/rilpivirine (CAB/ RPV), is also an option for maintaining viral suppression in people living with HIV, and lenacapavir (Yeztugo), approved for treatment, can also be used as a longacting HIV prevention tool in certain populations. In 2024, IAM treated 428 patients across IAM clinics— 113 on cabotegravir (Apretude) and 315 on rilpivirine (Cabenuva).
LAI Antiretroviral Therapy for HIV Treatment
LAI therapy is a highly effective alternative for some people with HIV and those at risk who have barriers to taking daily pills. This advanced approach to both HIV treatment and HIV prevention provides treatment through monthly, bimonthly, or semi-annual injections. A combination of long-acting Cabotegravir and Rilpivirine (Cabenuva) and Lenacapavir (Sunlenca) is available. Patients can receive injections at the IAM location where they receive PrEP or primary care.
IAM provides full support for patients receiving LAI therapy. This includes: assessing patient needs and eligibility for LAI; providing in-depth education on treatment options and their benefits; helping with insurance and pre-authorization (most plans, including Medicare/Medicaid accepted); patient advocacy to help patients get the best insurance coverage available; providing injections by specialized experts; offering ongoing monitoring and follow-up care.
IAM accepts referrals from health care providers within the Mount Sinai Health System, community health care providers, and self-referrals. Our goal is to provide the care patients need as efficiently as possible.
IAM Accomplishments
IAM’s four clinics provide comprehensive prevention, care, and treatment services to a diverse group of people and populations. Our patients include people seeking primary care, people with HIV, and people taking HIV prevention medication, people returning to the community from jails and prisons, people who identify as transgender and gender diverse, and many others. We have streamlined clinic flow and operations, and have improved our outreach, linkage, and retention procedures to support our communities with improved health care and quality of life. We provided primary care and supportive services to more than 18,000 individuals in 2024.
• In 2024, IAM provided an overall 340B benefit to the Health System of $18,741,856. (This is a federal program that allows health providers to use savings from discounted drugs to expand access to care.)
• In 2024, new grants totaling $13.8 million were added to our current portfolio.
• In 2024, 5,123 individuals (MD/DO, NP, PA, RN, PharmD, etc.) attended 114 clinical education training events focused on HIV, hepatitis C and/or drug user health, conducted by IAM’s Clinical Education Initiative.
• In 2024, IAM’s New York State Department of Healthfunded TelePrEP Program served 170 patients. TelePrEP is a virtual service that has served more than 330 patients since its inception in 2022, with a benefit of more than $650 million from 340B.
IAM provides a “one-stop shop” for comprehensive health services.
IAM provides multiple services under one roof, addressing health care needs and the social determinants of health. Each clinic provides services to address the needs of their community.
Certified Specialty Pharmacies, on-site at the Samuels Clinic and the Comprehensive Health Program, serve all four IAM clinics and are open the same hours.
• Pharmacy staff are available 24/7
• Pharmacies provide free delivery to all five boroughs, Long Island, and upstate NY
Care Coordination Program at all four clinics provides navigation and medical and social services coordination, virtual directly observed therapy, health education, and adherence support for people with HIV.
Project Safety, Harm Reduction, And Recovery for Everyone (Project SHARE) at Jack Martin Fund Center and Peter Krueger Clinic, provides support to reduce the negative impact of drugs and/or alcohol use on people with HIV: individual and group counseling, crisis intervention, overdose prevention and education, and art/recreational therapy.
Food and Nutrition Services program at Samuels and Jack Martin Fund Center clinics provides nutrition assessments and plans, individual and group nutrition counseling, workshops, and food voucher support for those in need, and trips to New York City neighborhoods to sample diverse healthy cuisines.
Comprehensive Dental Services at the Jack Martin Fund Center and Samuels Clinics include diagnosis and treatment of dental and oral diseases, routine dental hygiene, cleanings, and X-rays.
Integrative Medicine located at the Jack Martin Fund Center includes massage, yoga, acupuncture, meditation, and other stress reduction therapies to help address a variety of issues, including pain, insomnia, anxiety, and chronic disease management.
Pain Management Services are available at the Peter Krueger Clinic, Jack Martin Fund Center, and Comprehensive Health Program for those living with chronic pain.
We fulfill the health needs of all communities and populations in New York City.
Formerly Incarcerated Population: IAM’s Coming Home Program, located at IAM’s Jack Martin Fund Center, addresses the physical, mental, and social well-being of formerly incarcerated people after they return to the community from prison or jail. In 2024, the program provided services to 230 formerly incarcerated people; 21 percent attended a social work visit, and all attended a primary care provider visit.
Women, Infants, Children, and Youth (WICY): Located at the Jack Martin Fund Center and Samuels clinics, our WICY Program provides primary and specialty medical care and support services, including treatment adherence support, OB/GYN care, specialty care, mental health, substance use, oral health, nutrition, and case management for people with HIV. In 2024, IAM’s Ryan White WICY Program, funded by a federal Part D grant, served 2,012 women, infants, children, and youth with HIV.
Young Adults: IAM’s Young Adult Sexual Services (YASS!) Program serves young men who have sex with men. The team provides point-of-care HIV/STI testing, conducts presentations, and establishes new partnerships with sex venues and community-based organizations. In 2024, YASS! staff provided 340 encounters to 105 clients who are young men who have sex with men. On social media, YASS! garnered nearly 400 interactions, reached nearly 3,000 accounts, secured a total of 926 followers, and 389 likes on posts.
Drug User Health: IAM’s services to people who use drugs are low threshold, peer driven, and trauma informed. We strive for them to be nonjudgmental and stigma free. IAM’s harm-reduction program, Project SHaRE, and the Jack Martin Fund Center’s Coming Home Program both employ a Certified Alcoholism and Substance Abuse Counselor. Project SHaRE served 44 people with HIV in 2024.
Older People with HIV: IAM’s Peter Krueger Clinic has a program specifically for older people with HIV, developed through the Mount Sinai Department of Geriatrics and Palliative Care. The care model includes a fully developed team that includes a geriatrician (a physician who specializes in the care of older adults), a nurse, a social worker, pharmacist, and community health worker. During 2024, Angela Condo, MD, completed 212 visits for 106 patients. In line with the goal of developing effective programs that can be replicated, the Department of Geriatrics and Palliative Care is creating a fellowshiplike training program, guided by a master educator in geriatrics, where learners from multiple disciplines can be taught the core skills of comprehensive care for older adults with HIV.
LGBTQIA Health Services: IAM provides health care and supportive services to people who are lesbian, gay, bisexual, transgender, nonbinary, gender nonconforming, queer and/or questioning, intersex, asexual, and others who choose to self-identify in countless affirmative ways. We provide a full range of services including primary care, specialty care, mental health services, geriatric services, PrEP and PEP, HIV, STI and hepatitis C virus testing, social work, and care coordination. IAM has numerous programs that serve LGBTQIA individuals, including the PlaySure Network 2.0 Program, which offers a comprehensive package of HIV prevention, care, mental health, substance use, and supportive services using an equity-focused one-stop-shop and holistic approach; Voices in Partnership; the Center for Transgender Medicine and Surgery; and the Keith Haring Foundation Pediatric and Youth Gender Center.
New Programs in 2024
Leadership Training Series
In conjunction with the Mount Sinai Health System’s Office of Talent Development and Learning, IAM’s leadership team implemented a customized multi-year leadership training program for IAM managers and staff to cultivate effective, values-based leadership across all levels of the organization.
From the beginning, this effort was about more than just training—it was about building a shared language, fostering psychological safety, and equipping leaders to develop and motivate individuals and teams to reach their full potential.
Spanning three cohorts, the program provided consistent tools, encouraged accountability, and strengthened camaraderie among IAM’s leadership. Together, the participants explored a number of topics, including psychological safety, feedback, challenging conversations, designing great teams, delegation, and generational dynamics—laying the foundation for sustained growth and impact. Sessions in 2024 included: Celebrate and Elevate: Impactful Leadership Strategies for Recognition and Appreciation; Emotional Intelligence; and Coaching Approach.
The mission of Talent Development and Learning is to help Mount Sinai faculty and staff to learn, grow and achieve and make Mount Sinai a place where everyone thrives. By fostering a culture of continuous learning, the department provides the tools, inspiration, and support needed to unlock full potential and make a real impact in health care for Mount Sinai’s patients, its people, and the world.
Program Spotlight: Mount Sinai Comprehensive Program of Integrated Care for Older Adults With HIV
The Mount Sinai Comprehensive Program of Integrated Care for Older Adults with HIV, serves people with HIV (PWH) aged 50 and older. Its program model was developed to screen for geriatric syndromes, help patients maintain their functional status, and improve wellness and overall quality of life in older adults with HIV. High quality geriatric consultations, provided by the interdisciplinary team, focus on maintaining function and discussing what matters most to patients.
Directed by Angela Condo, MD, a board-certified internist and geriatrician and Assistant Professor of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai, the program uses an interdisciplinary geriatric team model to support healthy aging within the Mount Sinai Health System. The program currently operates at IAM’s Peter Krueger Clinic.
Patients are referred from across the system to be seen by an interdisciplinary team, consisting of Dr. Condo, nursing staff with experience in the care of older adults with HIV, a social worker and a pharmacist. The program’s Community Health Worker helps patients with referrals and connects patients to needed services based upon their individual assessment and plan.
The program performs a comprehensive assessment of each patient, including: a geriatric assessment; cognitive screening and evaluation of memory impairment; falls screening and evaluation of mobility; assessment of medications; assessment of function and psychosocial needs; assessment of disease understanding; assistance with navigating the health care system; and assistance with advance care planning and discussing what matters most. During 2024, Dr. Condo completed 212 visits for 106 patients.
IAM is exploring a collaboration between the Peter Krueger Clinic and Senior Planet, ( seniorplanet.org/classes/), a stand-alone community center dedicated to leveraging the power of technology to improve the way we age. Senior Planet hosts free classes, workshops, talks, and social and cultural events, offering older New Yorkers age 60 and over a comfortable space to learn, work and explore new ways to thrive in today’s digital world. IAM is excited about the possibilities this partnership brings for older adults living with HIV—enhancing digital skills, boosting social connection, and supporting greater independence. Senior Planet’s fun, engaging programs in tech, wellness, and healthy aging are very much in line with holistic approach to care. IAM is looking forward to officially launching this collaboration in spring 2025, once Senior Planet is settled into their new Midtown space.
We reduce HIV transmission in our communities, and we improve health outcomes and quality of life for people with HIV.
HIV Testing:
• IAM’s community-based outreach efforts, in addition to innovative social media strategies, continue to successfully help thousands of individuals with access to affordable prevention and sexual health services.
• In 2024, we provided 4,554 rapid HIV tests.
Diagnosed with HIV and Living with HIV:
• For those newly diagnosed with HIV, we provide immediate linkage to antiretroviral treatment per the state’s testand-treat protocols. Programs are available to assist people with receiving care and treatment at low or no cost.
• IAM provided medical services to 8,876 people with HIV in 2024.
• IAM patients with HIV maintained an average viral load suppression rate of 93 percent. This helps those who are living with HIV to reduce their illness, maintain a healthy lifestyle, and live longer, while preventing further transmission to others.
• Injectable HIV treatment is now FDA approved, and provided at IAM. We have developed policies and procedures to efficiently and optimally integrate this service into our clinic flow.
HIV Prevention for Those Who Are HIV-Negative:
• We helped 3,173 individuals at risk for HIV receive pre-exposure prophylaxis (PrEP), which prevents HIV infection if taken daily. We provide assistance to underinsured or uninsured patients with accessing PrEP medications at low or no cost.
• Injectable PrEP medication is also FDA approved, and IAM has developed procedures and policies, and instituted this service in 2023.
For Those Who Were Exposed to HIV:
• We linked 222 people to post-exposure prophylaxis (PEP), which prevents HIV infection when taken after potential HIV exposure. We administer the New York City and New York State 24/7 PEP Hotline, which links people to immediate or next-day PEP appointments, with access to free PEP starter packets.
Center for Transgender Medicine and Surgery (CTMS)
Clinical Services: In 2024, more than 4,500 transgender and gender-diverse (TGD) patients were actively receiving gender-affirming medical care with Mount Sinai Health System providers. In addition, more than 1,100 gender-affirming surgeries were performed, with surgeries now happening at The Mount Sinai Hospital, Mount Sinai West, and Mount Sinai Morningside, along with several ambulatory locations. The Center for Transgender Medicine and Surgery (CTMS) was launched in 2016, and is the most comprehensive TGD program in the country. To date, more than 15,000 TGD patients have received gender-affirming care through CTMS. The Center’s medical services include primary care, endocrinology, plastic surgery, gynecology, urology, otolaryngology, and mental health services. Spiritual care is available as part of our comprehensive interdisciplinary approach to care for inpatient surgical patients. During 2024, two new endocrinologists joined the CTMS team.
Education/Research: In 2024, CTMS added a New York State-funded transgender medicine fellowship. The fellowship joins our existing Mount Sinai LGBTQ fellowship, our dedicated CTMS plastic surgery fellowship, our CTMS psychiatry fellowship, and our CTMS Genitourinary fellowship. In addition, gender-affirming surgery continued as a core rotation for the Mount Sinai Plastic Surgery Residency, and gender-affirming hormone therapy continued as a core rotation for the Mount Sinai Endocrinology Fellowship program. The Mount Sinai free online course for primary care providers in transgender health care (www.coursera.org/learn/transgender-medicine) was used by approximately 6,000 students worldwide in 2024. In 2024, we published more than 20 papers across the range of gender-affirming care, including complication prevention for surgeries, spiritual care utilization for transgender patients undergoing surgery, and evidence-based best practices for gender-affirming hormone therapy.
The Mount Sinai Team at WPATH in Lisbon, Portugal, September 2024
In September 2024, at the World Professional Association for Transgender Health (WPATH) 28th Scientific Symposium, “A Gender Diverse World in Global Unity,” Joshua Safer, MD, FACP, FACE, Executive Director of CTMS, and others from Mount Sinai, presented leading-edge research on hormone therapy for transgender and gender-diverse patients. This presentation was one of 17 delivered by the Mount Sinai team, showcasing their commitment to advancing knowledge and promoting access, equity, and inclusion in health care. The symposium, held in Lisbon, Portugal, brought together medical experts, advocates, students, and colleagues from around the world to share insights and collaborate on advancing transgender and gender-diverse health care.
We provide education to New York
State medical providers on HIV primary care, HIV prevention, hepatitis C, and drug user health.
During 2024, IAM’s Clinical Education Initiative (CEI) trained 5,123 clinicians (MD/DO, NP, PA, RN, PharmD, etc.) through 114 clinical education activities focused on HIV, hepatitis C and/or drug user health. Funded by the New York State Department of Health AIDS Institute, the CEI aims to improve statewide health outcomes through free programming, including: conferences; webinars; ECHO tele-mentoring sessions; trainings for organizations (in-person or remote); comprehensive preceptorship programs; CEI warm-line (support for people who are struggling but not in crisis); customized technical assistance; YouTube videos; podcast episodes; and clinical tools.
IAM operates two of the Initiative’s statewide Centers of Excellence: the HIV Primary Care and Prevention Center of Excellence and the Hepatitis C and Drug User Health Center of Excellence. The HIV Primary Care and Prevention Center of Excellence is a statewide clinical education program addressing HIV screening, PEP and PrEP, and HIV diagnosis and treatment. The Center reaches primary care providers and other disciplines working in clinical settings such as local health departments, community health, family practice, and emergency medicine. The Center staffs the CEI line, a warm-line for clinical consultation, for inquiries related to HIV treatment, PEP, PrEP, and maternal-infant exposure to HIV.
CEI Participants, 2024
In addition to providing clinical education on HIV primary care (e.g., screening, diagnosis, treatment, prevention, managing comorbidities), the Center delivers trainings to health care professionals on providing LGBTQaffirming care.
The Hepatitis C and Drug User Health Center of Excellence serves as a statewide clinical education program to address both Hepatitis C and drug user health. The Center establishes relationships and collaborates with primary care and other front-line providers, as well as substance use, addiction, and mental health clinicians. The Center prioritizes reaching upstate New York providers through collaborations with local Departments of Health, Area Health Education Centers, opioid treatment programs, clinics, and hospitals. The Center also staffs the Clinical Education Initiative warm-line for case-based educational consultation on Hepatitis C clinical care and drug user health. In addition, the Center is committed to creating clinical education resources and training activities that promote health equity and address the ongoing stigma and discrimination faced by individuals who use drugs.
In April 2024, we hosted a clinical preceptorship program in collaboration with the Erie County Medical Center to provide hands-on technical assistance. Eight participants were required to participate in requisite training prior to clinical shadowing to learn from experienced providers by sitting in on patient visits and observing clinical care. A brief evaluation survey demonstrated that participants were pleased with the program; one participant reported, “This was an amazing program filled with practical knowledge, insights and experienced providers. I would highly recommend it to all of my colleagues.”
Patient Experience
IAM receives input and feedback from our clients in both formal and informal ways. These include patient satisfaction surveys, patient feedback surveys, feedback boxes at each of IAM’s clinics, and patient groups including those focused on specific populations (i.e., senior group). IAM’s Consumer Advisory Boards meet monthly or quarterly remotely for each of the four clinics and CTMS. This ensures continued valuable input and provides optimal patient and family involvement in assessing patient needs; designing, delivering, and evaluating services; and sustaining program improvements. Members consist of a cross representation of IAM’s patients.
Patient Testimonials
Comprehensive Health Program-Downtown Patients:
“I needed assistance with regards to a pharmacy and Julia Tanner helped me immensely. She is a true professional and an asset to Mount Sinai.”
“I’m extending my gratitude to my primary care physician, Dr. Urbina, and to Anna Kwok. Both maintain the highest standards of professionalism, and proactively handle any matters that I need assistance with.”
Samuels Clinic Patients:
“I’ve been SO lucky to have Dr. Lugo as my primary care physician, she’s truly a wonderful, caring, and compassionate doctor.”
“Michael Olivier-De La Torre, DNP, engages me in the decision of other treatment options. We engage in lab reports.”
“Since I am in a wheelchair, the entire Dental team was very helpful in getting me onto the chair.”
“Dr. Moy is a fantastic dentist who always addresses my concerns.”
Jack Martin Fund Center Patients:
“I am writing to express my sincere gratitude for the excellent assistance provided to me by Jessica Roca, who helped me to navigate the process of working with HRA to ensure that my housing transfer was successful. Jessica is one of the main reasons that I am now living in a healthy and safe living environment. I will always appreciate and remember her kindness.”
“As a new patient here, I’m so happy with joy because of the care this team has given me. I’m glad to be here and want more people to experience this!”
Peter Krueger Clinic Patients:
“Friendly environment; easy to schedule any appointments. Provider calls on time and answers all my questions. I enjoy Project SHaRE/Dale’s group (harm reduction and OG groups). I like having access to escorts if needed for my appointments.”
Community Partnerships
IAM has a successful history in collaborating and coordinating services for our targeted population via partnerships with community providers. Our active referral linkages with more than 60 agencies help connect patients with supplementary services that include housing, vocational training, food pantries, meals and vouchers, drug treatment and mental health services, legal services, support groups, and additional health services. IAM staff participate in numerous community-oriented groups that focus on planning and targeting HIV prevention, testing and treatment
Community Partnerships services throughout New York City and New York State, and addressing the needs of priority populations. These include the New York State LGBT Health & Human Services Network (The Network), HIV Health and Human Services Planning Council of New York, HIV Planning Group, HIV Advisory Body, Public Health Solutions Community Advisory Group, New York Knows, and New York Links. IAM continues to be heavily involved with the New York State HIV Medicaid Coalition to identify opportunities, educate and advocate, and generate best practices and lessons learned.
Continuous Quality Improvement
2024 Year-End Quality Improvement and Preventive Care Highlights
IAM’s Continuous Quality Improvement Program was established 11 years ago to ensure that IAM achieves our vision to provide the highest quality of care to every patient, at every visit. Program staff work closely with each clinic’s multidisciplinary teams to plan, assess, measure, and implement improvements in the coordination and delivery of quality care and services for all patients, across all clinics and programs. At the heart of our quality work is improving both patient experience and patient outcomes. IAM’s Quality Infrastructure is governed by a Continuous Quality Improvement plan, updated annually, that speaks to the goals and clinical focuses for each year, and the role that each team member plays, individually and collectively, to advance our quality initiatives. In 2024, the IAM team was able to continue, and expand upon, our high-quality service provision and commitment to quality improvement. IAM-wide clinic and program quality improvement projects in 2024 focused on raising performance in key clinical areas including pre-visit planning, cervical cancer screening, breast cancer screening, colorectal cancer screening, blood pressure monitoring, and diabetic eye exams, as well as the creation of various dashboards and tracking tools to measure performance improvement. Additionally, as always, we supported improvements around viral load suppression, both for IAM and for our New York State Department of Health AIDS Institute State Reporting, continuing to exceed the Ending the Epidemic benchmark of 85 percent.
• Breast Cancer Screening: IAM achieved a 70 percent screening rate, driven by targeted efforts such as the expansion of the Mobile Mammography initiative. New screening events were successfully launched at the Jack Martin Fund Center and the Samuels Clinic, resulting in 44 patients screened and improved access to preventive care.
• Colorectal Cancer Screening: Screening rates rose to 71 percent. Contributing strategies included increasing Cologuard test orders, enhancing followup on unreturned kits, and streamlining colonoscopy referral workflows to ensure timely patient access.
• HIV Viral Suppression: IAM reached a 93 percent viral suppression rate among its HIV-positive patients. As part of the INPact Now Collaborative, Care Coordination teams at Samuels and Harlem Clinics led a viral load suppression QI project focused on improving quarterly case conference completion— achieving an 85.79 percent completion rate in Q3 and significantly supporting viral suppression outcomes.
• Cervical Cancer Screening: Screening rates climbed to 81 percent. IAM clinics implemented several focused interventions, including ongoing data analysis, patient list scrubbing to identify eligible individuals, utilizing alternative providers and locations, and piloting new outreach strategies to increase patient engagement.
• Depression Screening and Follow-Up: IAM reached an 89.87 percent rate in screening for depression and implementing follow-up plans, highlighting a strong commitment to integrated behavioral health.
• PCMH Accreditation: IAM successfully renewed its Patient-Centered Medical Home (PCMH) accreditation, reinforcing our commitment to delivering comprehensive, high quality, patientcentered primary care.
As we close out 2024, the Institute for Advanced Medicine reflects on a transformative year grounded in innovation, collaboration, and a deepened focus on advancing quality improvement through primary and preventive care. The Quality Improvement Program continues to play a central role in this work, supporting clinics by partnering closely with providers, staff, and leadership to identify care gaps, implement datainformed strategies, and monitor outcomes in real time. Across our clinics, these efforts have strengthened our commitment to delivering equitable, patient-centered care and building sustainable workflows that elevate the quality of services for all IAM patients. From expanding access to screenings and chronic disease management to advancing health equity, our collective work has led to measurable improvements in care, no doubt impacting the lives, health, and longevity of the patients we serve. We also recognize the importance of our patients and their involvement in our continuous quality improvement efforts. During 2024 and beyond, we will continue to expand our partnerships with each clinic’s Consumer Advisory Boards to engage them further in our program efforts, and to ensure that our clinical focuses align with the priorities of our patients.
Awards, Presentations, and Publications
In 2024, IAM staff disseminated more than 20 publications, and provided more than 20 presentations at conferences, webinars, trainings, and media events throughout the world. In addition, our staff is involved in addressing HIV long-acting therapies, including long-acting injectables, functional cures, anal precancer in women, anal cancer and dysplasia, opioid prescribing, chronic pain, autonomic neuropathy, HIV-associated cognitive impairment, Mpox, and people with HIV who have COVID-19.
Awards
In September 2024, the Health Resources and Services Administration boosted the FY25 budget for the Special Projects of National Significance project focused on HIV and aging by 25 percent, which provides an additional opportunity to amplify dissemination of the healthy aging program model implemented by the team of Angela Condo, MD.
In November 2024, the IAM received a Ryan White HIV/AIDS Program Part A award of $461,593 from the New York City Department of Health and Mental Hygiene, Public Health Solutions, to provide continued harmreduction services at the Peter Krueger Clinic and expand them to the Jack Martin Fund Center, to better meet the increasing need for these services in Harlem.
Selected Presentations and Conferences
• ENDO 2024
• 93rd Annual Meeting, Plastic Surgery Meeting
• 23rd Annual Pain Medicine Meeting
• American Urological Association Annual Meeting
• United States Professional Association for Transgender Health
• USPATH)/World Professional Association for Transgender Health Annual Conference
• Conference on Retroviruses and Opportunistic Infections
• International AIDS Society Conference
• Synchronicity—The 10th Annual National Conference
• National Ryan White Conference on HIV Care and Treatment
• ALAI-UP Convening (the annual conference of the 8 ALAI grantees across the United States)
• New York State Department of Health 2024 Ending the Epidemic Summit
• New York State Department of Health AIDS Institute’s Digital Health Initiative
• New York State Hepatitis C and Drug User Health Annual Conference
• New York State HIV Primary Care and Prevention Annual Conference
• Mount Sinai Health System Medical Student Presentations
Selected Publications
Coelho C, Fantin R, Bozarth B, Cohn H, Lobo I, Nardulli J, Srivastava K, Altman D, Lugo LA, PVI Study Group, Simon V. 01 May 2024. Human antibody responses to circulating monkeypox virus demonstrate the need for the first mpox-specific vaccine. The Journal of Immunology, Volume 212, Issue 1_Supplement, May 2024, page 1560_4437.
Garcia EA, Foote MMK, McPherson TD, Lash MK, Bosompem AN, Bouscaren A, Chan J, DiLorenzo MA, Feihel D, Fowler RC, Gandhi V, Jenny-Avital ER, Kopping EJ, Mazo D, McLean J, Mgbako O, Sayegh MN, Shaw RN, Su M, Meissner JS, Wang JC, Wen W, Winters JC, Zeana CB, Zucker J, Wong M. Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City. Open Forum Infect Dis. 2024;11(6):ofae294. doi: 10.1093/ofid/ofae294. PMID: 38868307; PMCID: PMC11168585.
Grant Portfolio
In 2024, IAM received more than $14.5 million in grants to support new and existing programs and approximately 60 percent of IAM staff.
and Treatment Programs
•
•
•
•
•
•
•
•
•
•
•
•
• Dental Services
• Coming Home Program
•
•
• Voices in Partnership (VIP) Program
Coordination
Center for Transgender Medicine and Surgery
•
•
We wish to thank the following funders for their contribution to our programs. Our work would not be possible without their support.
• Keith Haring Foundation
• New York Community Trust
• New York City Department of Health and Mental Hygiene/Public Health Solutions
• New York State Department of Health AIDS Institute
• Substance Abuse and Mental Health Services Administration
• US Department of Health and Human Services – Health Resources and Services Administration
Our Locations
1 Jack Martin Fund Center
Mount Sinai Harlem Health Center 158 West 124th Street, Third Floor New York, NY 10027
332-243-0100
2 Samuels Clinic
Mount Sinai West 1000 10th Avenue, Suite 2T New York, NY 10019
212-523-6500
3 Comprehensive Health Program 275 Seventh Avenue, 12th Floor New York, NY 10001
212-604-1701
4 Center for Transgender Medicine and Surgery
275 Seventh Avenue, 12th Floor New York, NY 10001 212-604-1730
5 Peter Krueger Clinic 275 Eighth Avenue New York, NY 10011 212-420-2620
